| [1] |
.
[J]. Clinical Focus, 2023, 38(10): 935-939.
|
| [2] |
.
[J]. Clinical Focus, 2023, 38(6): 559-563.
|
| [3] |
.
[J]. Clinical Focus, 2023, 38(4): 373-376.
|
| [4] |
Cao Yumeng, Zhang Haiyan, Liu Lixin.
Correlation between pathological changes and serum ferritin and iron levels in nonalcoholic fatty liver disease: A meta-analysis
[J]. Clinical Focus, 2023, 38(3): 197-207.
|
| [5] |
.
[J]. Clinical Focus, 2022, 37(9): 846-854.
|
| [6] |
Zhang Limin, Sun Jun.
Predictive value of FIB-4 in patients with metabolic-associated fatty liver disease complicated with colorectal adenomatous polyps
[J]. Clinical Focus, 2022, 37(4): 334-338.
|
| [7] |
Wen Jie.
Correlation analysis between atherogenic index of plasma and nonalcoholic fatty liver disease
[J]. Clinical Focus, 2022, 37(1): 35-38.
|
| [8] |
Li Guohuan, Xie Xu, Huang Zhixia, Zhang Mingye, Tang Yunyun.
Quantitative evaluation of transient elastography and acoustic radiation force pulse imaging for non-alcoholic fatty liver disease
[J]. Clinical Focus, 2021, 36(6): 535-539.
|
| [9] |
Zhang Ying, Wang Chunsheng.
Effects of Jiangzhi Ligan Granules combined with simvastatin on hepatic biochemical indexes, leptin and adiponectin in treatment of NAFLD
[J]. Clinical Focus, 2021, 36(1): 58-61.
|
| [10] |
Lu Xiaomin;Wang Zhenning;Yang Jun;Cui Zheng.
Detection of serum iron in alcoholic and non-alcoholic fatty liver disease
[J]. Clinical Focus, 2015, 30(9): 1033-1035.
|
| [11] |
WAN Shun-mei;WU Yong-sheng;ZHU Ping;LI Wan-jun;WAN Ping-xin;YANG Wei-jie;PAN Li.
Significance of oxygen free radical metabolism in nonalcoholic fatty liver in high-altitude regions
[J]. Clinical Focus, 2014, 29(6): 670-671672.
|
| [12] |
.
[J]. CLINICAL FOCUS, 2014, 29(4): 474-477.
|
| [13] |
.
[J]. Clinical Focus, 2013, 28(5): 540-542.
|
| [14] |
.
[J]. Clinical Focus, 2012, 27(22): 1977-1979.
|
| [15] |
.
[J]. Clinical Focus, 2012, 27(17): 1512-1513.
|
